RATIONALE: The determinants of immunoglobulin G (IgG) level and the risk of hypogammaglobulinemia (HGG) in patients with severe lung disease before and after lung transplantation are unknown. OBJECTIVES: We aimed to identify predictors of low IgG levels before and after lung transplantation. METHODS: We performed a retrospective cohort study of 40 consecutive lung transplant recipients at our center. Total IgG levels were measured before and serially after transplantation. Mild HGG was defined as IgG levels from 400-699 mg/dl; severe HGG was defined as IgG levels<400 mg/dl. MEASUREMENTS AND MAIN RESULTS: Before transplantation, six (15%) patients had mild HGG, and none had severe HGG. Patients with chronic obstructive pulmonary disease had lower IgG levels compared with patients with other diseases (independent of corticosteroid use and age; p=0.001) and an increased risk of mild HGG (p=0.005). The cumulative incidences of mild and severe HGG significantly increased after transplantation (58 and 15%, respectively, both p<0.04 compared with pretransplant prevalences). Lower pretransplant IgG level and treatment with mycophenolate mofetil were associated with lower IgG levels after transplantation (both p<0.05). Only lower pretransplant IgG levels were significantly associated with an increased risk of severe HGG after transplantation (p=0.02). CONCLUSIONS: Mild HGG is common in patients with severe chronic obstructive pulmonary disease, and the incidences of mild and severe HGG increase significantly early after lung transplantation. Baseline IgG levels and treatment with mycophenolate mofetil affect post-transplant IgG levels.
RATIONALE: The determinants of immunoglobulin G (IgG) level and the risk of hypogammaglobulinemia (HGG) in patients with severe lung disease before and after lung transplantation are unknown. OBJECTIVES: We aimed to identify predictors of low IgG levels before and after lung transplantation. METHODS: We performed a retrospective cohort study of 40 consecutive lung transplant recipients at our center. Total IgG levels were measured before and serially after transplantation. Mild HGG was defined as IgG levels from 400-699 mg/dl; severe HGG was defined as IgG levels<400 mg/dl. MEASUREMENTS AND MAIN RESULTS: Before transplantation, six (15%) patients had mild HGG, and none had severe HGG. Patients with chronic obstructive pulmonary disease had lower IgG levels compared with patients with other diseases (independent of corticosteroid use and age; p=0.001) and an increased risk of mild HGG (p=0.005). The cumulative incidences of mild and severe HGG significantly increased after transplantation (58 and 15%, respectively, both p<0.04 compared with pretransplant prevalences). Lower pretransplant IgG level and treatment with mycophenolate mofetil were associated with lower IgG levels after transplantation (both p<0.05). Only lower pretransplant IgG levels were significantly associated with an increased risk of severe HGG after transplantation (p=0.02). CONCLUSIONS: Mild HGG is common in patients with severe chronic obstructive pulmonary disease, and the incidences of mild and severe HGG increase significantly early after lung transplantation. Baseline IgG levels and treatment with mycophenolate mofetil affect post-transplant IgG levels.
Authors: Elbert P Trulock; Leah B Edwards; David O Taylor; Mark M Boucek; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2005-08 Impact factor: 10.247
Authors: Mark L Barr; Robert C Bourge; Jonathan B Orens; Kenneth R McCurry; W Steves Ring; Tempie E Hulbert-Shearon; Robert M Merion Journal: Am J Transplant Date: 2005-04 Impact factor: 8.086
Authors: M H Yamani; R K Avery; S D Mawhorter; J B Young; N B Ratliff; R E Hobbs; P M McCarthy; N G Smedira; M Goormastic; D Pelegrin; R C Starling Journal: J Heart Lung Transplant Date: 2001-04 Impact factor: 10.247
Authors: N S Goldfarb; R K Avery; M Goormastic; A C Mehta; R Schilz; N Smedira; L Pien; M T Haug; S M Gordon; L K Hague; J M Dresing; T Evans-Walker; J R Maurer Journal: Transplantation Date: 2001-01-27 Impact factor: 4.939
Authors: Douglas G Farmer; Omar M Kattan; Laura J Wozniak; Elizabeth Marcus; Susan Ponthieux; Villy Hwang; Ronald W Busuttil; Suzanne V McDiarmid; Robert S Venick Journal: Transplantation Date: 2013-05-15 Impact factor: 4.939
Authors: Sai S Duraisingham; Matthew Buckland; John Dempster; Lorena Lorenzo; Sofia Grigoriadou; Hilary J Longhurst Journal: PLoS One Date: 2014-06-27 Impact factor: 3.240
Authors: Juthaporn Cowan; Logan Gaudet; Sunita Mulpuru; Vicente Corrales-Medina; Steven Hawken; Chris Cameron; Shawn D Aaron; D William Cameron Journal: PLoS One Date: 2015-11-11 Impact factor: 3.240
Authors: Andrej A Petrov; Russell S Traister; Maria M Crespo; Fernanda P Silveira; Maylene Xie; Kara Coffey; Christopher R Ensor; Douglass Landsittel; Joseph M Pilewski Journal: Transplant Direct Date: 2018-07-12